Boule Diagnostics AB Stock Nasdaq Stockholm
Equities
SE0000437402
Advanced Medical Equipment & Technology
Sales 2024 * | 579M 54.12M 73.72M | Sales 2025 * | 609M 56.92M 77.54M | Capitalization | 398M 37.2M 50.68M |
---|---|---|---|---|---|
Net income 2024 * | 35M 3.27M 4.46M | Net income 2025 * | 43M 4.02M 5.47M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 47.3M 4.42M 6.02M | Net Debt 2025 * | 40.53M 3.79M 5.16M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.07
x | Employees | - |
Yield 2024 * |
2.29% | Yield 2025 * |
3.37% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
1st Jan change | Capi. | |
---|---|---|
+13.19% | 227B | |
+13.88% | 192B | |
+17.64% | 136B | |
+28.53% | 108B | |
+1.67% | 64.07B | |
+17.68% | 52.1B | |
+7.04% | 51.87B | |
+10.89% | 44.33B | |
+5.35% | 36.75B |